---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-023841"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2022-08-23T23:59:59+00:00"
generated_at: "2026-06-23T21:54:49.222584+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Nephros Chief Commercial Officer Wes Lobo resigns effective September 30, 2022

## Summary
- Wes Lobo notified Nephros of his resignation as Chief Commercial Officer on August 17, 2022.
- His resignation is effective no later than September 30, 2022.
- No successor or interim replacement has been announced.

## SEC filing metadata
- accession: 0001493152-22-023841
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2022-08-23T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315222023841/0001493152-22-023841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315222023841/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-023841
- JSON: https://secwatch.observer/filing/0001493152-22-023841.json
- Plain text: https://secwatch.observer/filing/0001493152-22-023841.txt

## Key facts
- Executive change
  Wes Lobo resigned as Chief Commercial Officer at NEPHROS INC.
  - Action: resigned
  - Role: Chief Commercial Officer
  source text: On August 17, 2022, Wes Lobo, Chief Commercial Officer of Nephros, Inc. (the “Company”), notified the Company that he is resigning his employment with the Company, to be effective no later than September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1196298/000149315222023841/0001493152-22-023841-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.